Cargando…

Using Bayes' Rule to Define the Value of Evidence from Syndromic Surveillance

In this work we propose the adoption of a statistical framework used in the evaluation of forensic evidence as a tool for evaluating and presenting circumstantial “evidence” of a disease outbreak from syndromic surveillance. The basic idea is to exploit the predicted distributions of reported cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Mats Gunnar, Faverjon, Céline, Vial, Flavie, Legrand, Loïc, Leblond, Agnès
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218722/
https://www.ncbi.nlm.nih.gov/pubmed/25364823
http://dx.doi.org/10.1371/journal.pone.0111335
_version_ 1782342464745504768
author Andersson, Mats Gunnar
Faverjon, Céline
Vial, Flavie
Legrand, Loïc
Leblond, Agnès
author_facet Andersson, Mats Gunnar
Faverjon, Céline
Vial, Flavie
Legrand, Loïc
Leblond, Agnès
author_sort Andersson, Mats Gunnar
collection PubMed
description In this work we propose the adoption of a statistical framework used in the evaluation of forensic evidence as a tool for evaluating and presenting circumstantial “evidence” of a disease outbreak from syndromic surveillance. The basic idea is to exploit the predicted distributions of reported cases to calculate the ratio of the likelihood of observing n cases given an ongoing outbreak over the likelihood of observing n cases given no outbreak. The likelihood ratio defines the Value of Evidence (V). Using Bayes' rule, the prior odds for an ongoing outbreak are multiplied by V to obtain the posterior odds. This approach was applied to time series on the number of horses showing clinical respiratory symptoms or neurological symptoms. The separation between prior beliefs about the probability of an outbreak and the strength of evidence from syndromic surveillance offers a transparent reasoning process suitable for supporting decision makers. The value of evidence can be translated into a verbal statement, as often done in forensics or used for the production of risk maps. Furthermore, a Bayesian approach offers seamless integration of data from syndromic surveillance with results from predictive modeling and with information from other sources such as disease introduction risk assessments.
format Online
Article
Text
id pubmed-4218722
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42187222014-11-05 Using Bayes' Rule to Define the Value of Evidence from Syndromic Surveillance Andersson, Mats Gunnar Faverjon, Céline Vial, Flavie Legrand, Loïc Leblond, Agnès PLoS One Research Article In this work we propose the adoption of a statistical framework used in the evaluation of forensic evidence as a tool for evaluating and presenting circumstantial “evidence” of a disease outbreak from syndromic surveillance. The basic idea is to exploit the predicted distributions of reported cases to calculate the ratio of the likelihood of observing n cases given an ongoing outbreak over the likelihood of observing n cases given no outbreak. The likelihood ratio defines the Value of Evidence (V). Using Bayes' rule, the prior odds for an ongoing outbreak are multiplied by V to obtain the posterior odds. This approach was applied to time series on the number of horses showing clinical respiratory symptoms or neurological symptoms. The separation between prior beliefs about the probability of an outbreak and the strength of evidence from syndromic surveillance offers a transparent reasoning process suitable for supporting decision makers. The value of evidence can be translated into a verbal statement, as often done in forensics or used for the production of risk maps. Furthermore, a Bayesian approach offers seamless integration of data from syndromic surveillance with results from predictive modeling and with information from other sources such as disease introduction risk assessments. Public Library of Science 2014-11-03 /pmc/articles/PMC4218722/ /pubmed/25364823 http://dx.doi.org/10.1371/journal.pone.0111335 Text en © 2014 Andersson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Andersson, Mats Gunnar
Faverjon, Céline
Vial, Flavie
Legrand, Loïc
Leblond, Agnès
Using Bayes' Rule to Define the Value of Evidence from Syndromic Surveillance
title Using Bayes' Rule to Define the Value of Evidence from Syndromic Surveillance
title_full Using Bayes' Rule to Define the Value of Evidence from Syndromic Surveillance
title_fullStr Using Bayes' Rule to Define the Value of Evidence from Syndromic Surveillance
title_full_unstemmed Using Bayes' Rule to Define the Value of Evidence from Syndromic Surveillance
title_short Using Bayes' Rule to Define the Value of Evidence from Syndromic Surveillance
title_sort using bayes' rule to define the value of evidence from syndromic surveillance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218722/
https://www.ncbi.nlm.nih.gov/pubmed/25364823
http://dx.doi.org/10.1371/journal.pone.0111335
work_keys_str_mv AT anderssonmatsgunnar usingbayesruletodefinethevalueofevidencefromsyndromicsurveillance
AT faverjonceline usingbayesruletodefinethevalueofevidencefromsyndromicsurveillance
AT vialflavie usingbayesruletodefinethevalueofevidencefromsyndromicsurveillance
AT legrandloic usingbayesruletodefinethevalueofevidencefromsyndromicsurveillance
AT leblondagnes usingbayesruletodefinethevalueofevidencefromsyndromicsurveillance